-

ATEC to Participate in Upcoming Conferences

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:

  • The 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025.
  • The RBCCM Medical Supplies & Devices Virtual Symposium virtually on August 18, 2025, from 10:00am – 11:00am ET.
  • The Piper Sandler MedTech and Diagnostics West Coast Bus Tour at The Ritz Carlton Laguna Niguel in Dana Point, CA at 7:55am PT.
  • The Wells Fargo 2025 Healthcare Conference beginning on September 3, 2025, at The Encore Boston Harbor in Everett, MA, with a fireside chat at 10:30am ET.

If available, the live webcasts will be accessible on ATEC’s Investor Relations website.

Inducement Awards Granted

As an inducement material to accepting employment with the Company, and in accordance with Nasdaq Listing Rule 5635(c)(4), ATEC today announced that the independent Compensation Committee of the Board of Directors has approved aggregate grants to 9 new employees (who are not executive officers) of, collectively, 11,967 restricted stock units (“RSUs”) under the Company’s 2016 Employment Inducement Award Plan. The RSUs will vest in equal annual installments on each of the first four anniversaries of the grant date, provided that the recipient remains continuously employed by ATEC as of such vesting date. In addition, the RSUs will vest fully upon a change of control of ATEC.

About ATEC

ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation MachineTM is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.

Contacts

Investor/Media Contact: 
Robert Judd, VP  
Finance & Investor Relations 
investorrelations@atecspine.com

Company Contact: 
J. Todd Koning 
Chief Financial Officer 
Alphatec Holdings, Inc. 
investorrelations@atecspine.com

Alphatec Holdings, Inc.

NASDAQ:ATEC

Release Versions

Contacts

Investor/Media Contact: 
Robert Judd, VP  
Finance & Investor Relations 
investorrelations@atecspine.com

Company Contact: 
J. Todd Koning 
Chief Financial Officer 
Alphatec Holdings, Inc. 
investorrelations@atecspine.com

More News From Alphatec Holdings, Inc.

ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2025, and recent corporate highlights. Second Quarter 2025 Financial Results   Quarter Ended June 30, 2025 Total revenue $186 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $142 million Non-GAAP operating expenses $12...

ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC’s Corporate Website. Dial-In To dial into the l...

ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results   Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAA...
Back to Newsroom